PN 112
Alternative Names: PN-112Latest Information Update: 08 Sep 2021
At a glance
- Originator PAEAN Biotechnology
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation